Enzo Biochem ($ENZ) picked up a $7 million settlement in its ongoing patent squabble with PerkinElmer ($PKI), resolving one of its many legal wrangles in life sciences. The suit was tied to alleged infringement of intellectual property related to diagnostics and sequencing, and Enzo has pursued similar claims against Roche Diagnostics ($RHHBY), LabCorp ($LH), Life Technologies and Affymetrix ($AFFY). News